Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma-Reference-Cited by-同舟云学术

Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma

Published:2013 Issue:1 Volume:1 Page:20
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:Journal for ImmunoTherapy of Cancer

Author:

Yuan Jianda,Ku Geoffrey Y,Adamow Matthew,Mu Zhenyu,Tandon Sapna,Hannaman Drew,Chapman Paul,Schwartz Gary,Carvajal Richard,Panageas Katherine S,Houghton Alan N,Wolchok Jedd D

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Reference32 articles.

1. Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines

2. Malignant Melanoma of the Skin: Long-term Follow-up and Time to First Recurrence

3. Systemic Therapy for Cutaneous Melanoma

4. A Pooled Analysis of Eastern Cooperative Oncology Group and Intergroup Trials of Adjuvant High-Dose Interferon for Melanoma

5. Melanoma Immunotherapy

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Role of Surgery with Electroporation in Melanoma: Chemotherapy, Immunotherapy, and Gene Delivery;Journal of Clinical Medicine;2024-06-29

2. Advanced micro/nano-electroporation for gene therapy: recent advances and future outlook;Nanoscale;2024

3. DNA Vaccines: History, Molecular Mechanisms and Future Perspectives;Journal of Molecular Biology;2023-12

4. Advances of Electroporation-Related Therapies and the Synergy with Immunotherapy in Cancer Treatment;Vaccines;2022-11-17

5. Intratumoral xenogeneic tissue-specific cell immunotherapy inhibits tumor growth by increasing antitumor immunity in murine triple negative breast and pancreatic tumor models;Cancer Letters;2022-10